Onyx Pharmaceuticals, Inc.
Data ndekọ gọọmentị
0ndị na-eso
2013tọrọ ntọala
Maka Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
Isi ụlọ ọrụCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Tọrọ ntọala2013
ỌnọdụNa-arụ ọrụ
Patent60 patent
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Banye iji hụ patentị 60 niile
Chọgharịa pọtụfoliyo patentị zuru ezu, tinyere nọmba mbipụta, ụbọchị na ezinụlọ.
Banye Mepụta akaụntụ site n'ozi-e gịỌ bụ n'efu
Site n'ịga n'ihu, ị na-ekweta Nkwekọrịta onye ojiji, Amụma nzuzo na Amụma kuki nke Heelky.
Nyocha
Enweghị nyocha ugbu a. Ị rụrụ ọrụ na Onyx Pharmaceuticals, Inc.? Bụrụ onye mbụ kekọrịta ahụmahụ gị.
Ozi iwu
| Aha iwu | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Lee na GLEIF ↗ |
| Adreesị edebanyere aha | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Ọnọdụ | Na-arụ ọrụ |
Isi mmalite: GLEIF · emelitere 16 Ọktoba 2026
Kọntaktị & njikọ
Ebe
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Nke a ọ bụ ụlọ ọrụ gị?
Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.
Kwuo ibe aSonye na Heelky iji jikọọ, were ndị ọrụ ma too
Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.
Sonye ugbu a — ọ bụ n'efu